Kimler BF - Search Results

1

Beyond tamoxifen new endpoints for breast cancer chemoprevention, new drugs for breast cancer prevention.

Fabian CJ, Kimler BF. Fabian CJ, et al. Among authors: kimler bf. Ann N Y Acad Sci. 2001 Dec;952:44-59. doi: 10.1111/j.1749-6632.2001.tb02727.x. Ann N Y Acad Sci. 2001. PMID: 11795443 Review.

2

Recruitment with high physiological doses of estradiol preceding chemotherapy: flow cytometric and therapeutic results in women with locally advanced breast cancers--a Southwest Oncology Group study.

Fabian CJ, Kimler BF, McKittrick R, Park CH, Lin F, Krishnan L, Jewell WR, Osborne CK, Martino S, Hutchins LF, et al. Fabian CJ, et al. Among authors: kimler bf. Cancer Res. 1994 Oct 15;54(20):5357-62. Cancer Res. 1994. PMID: 7923165

3

Prevalence of aneuploidy, overexpressed ER, and overexpressed EGFR in random breast aspirates of women at high and low risk for breast cancer.

Fabian CJ, Zalles C, Kamel S, Kimler BF, McKittrick R, Tranin AS, Zeiger S, Moore WP, Hassanein RS, Simon C, et al. Fabian CJ, et al. Among authors: kimler bf. Breast Cancer Res Treat. 1994;30(3):263-74. doi: 10.1007/BF00665967. Breast Cancer Res Treat. 1994. PMID: 7981444

4

Identification of a chemoprevention cohort from a population of women at high risk for breast cancer.

Fabian CJ, Kamel S, Zalles C, Kimler BF. Fabian CJ, et al. Among authors: kimler bf. J Cell Biochem Suppl. 1996;25:112-22. J Cell Biochem Suppl. 1996. PMID: 9027607 Clinical Trial.

5

Breast cytology and biomarkers obtained by random fine needle aspiration: use in risk assessment and early chemoprevention trials.

Fabian CJ, Zalles C, Kamel S, Zeiger S, Simon C, Kimler BF. Fabian CJ, et al. Among authors: kimler bf. J Cell Biochem Suppl. 1997;28-29:101-10. J Cell Biochem Suppl. 1997. PMID: 9589354

6

Models for early chemoprevention trials in breast cancer.

Fabian CJ, Kimler BF, Elledge RM, Grizzle WE, Beenken SW, Ward JH. Fabian CJ, et al. Among authors: kimler bf. Hematol Oncol Clin North Am. 1998 Oct;12(5):993-1017. doi: 10.1016/s0889-8588(05)70038-1. Hematol Oncol Clin North Am. 1998. PMID: 9888018 Review.

7

Breast cancer chemoprevention trials using the fine-needle aspiration model.

Kimler BF, Fabian CJ, Wallace DD. Kimler BF, et al. J Cell Biochem Suppl. 2000;34:7-12. J Cell Biochem Suppl. 2000. PMID: 10762008

8

Incidence of BRCA1/2 germ line alterations in a high risk cohort participating in a phase II chemoprevention trial.

Klemp J, Brady D, Frank TS, Kimler BF, Fabian CJ. Klemp J, et al. Among authors: kimler bf. Eur J Cancer. 2000 Jun;36(10):1209-14. doi: 10.1016/s0959-8049(00)00112-x. Eur J Cancer. 2000. PMID: 10882858 Clinical Trial.

9

Short-term breast cancer prediction by random periareolar fine-needle aspiration cytology and the Gail risk model.

Fabian CJ, Kimler BF, Zalles CM, Klemp JR, Kamel S, Zeiger S, Mayo MS. Fabian CJ, et al. Among authors: kimler bf. J Natl Cancer Inst. 2000 Aug 2;92(15):1217-27. doi: 10.1093/jnci/92.15.1217. J Natl Cancer Inst. 2000. PMID: 10922407

10

Breast cancer risk prediction: should nipple aspiration fluid cytology be incorporated into clinical practice?

Fabian CJ, Kimler BF. Fabian CJ, et al. Among authors: kimler bf. J Natl Cancer Inst. 2001 Dec 5;93(23):1762-3. doi: 10.1093/jnci/93.23.1762. J Natl Cancer Inst. 2001. PMID: 11734584 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

214 results

Search Page